Nano Labs Develops Novel Test For TB
Visit CBS Detroit's
DETROIT — NanoLabs Corp. (OTCQB:CTLE) Monday announced promising new biological diagnostics test results obtained n a miniaturized tuberculosis biosensor platform.
The company successfully developed a point-of-care biosensor and said it’s offering the biotech industry with proposals for miniaturization and commercialization.
Company officials said four innovative systems are being proposed, with the objective of creating a low-cost, high-sensitivity and rapid diagnostic platform capable of being used in remote lcoations allowing for monitoring of critical infectious diseases, including tuberculosis.
The company’s aim is to establish a commercial biosensors using modern techniques by either applying common Micro-Electro-Mechanical-Systems batch processes, or by using simpler and more modular methods such as soft lithography or laser ablation.
“It is important to note that innovative, comprehensive strategies for obtaining a functional prototype will need to be carefully addressed for all projects, at any development stage,” said Victor Castano, chief research and innovation officer at Nano Labs. “This includes packaging, interconnect with outside world, and modular integration on circuits or with some sort of display.”
The company is in discussions with industry leaders to assess product development strategies and additional research required over the next twelve months to advance the commercialization of the product.
“We are looking at partnerships that bring the experience, dedication and the vision to address critical world health issues, like tuberculosis,” said Bernardo Chavarria, president of Nano Labs. “We expect that new research areas and biosensor solutions will emerge from this project and therefore present a much larger scope of practical applications that need to be further investigated. This technology has enormous potential and will bring exciting new opportunities to our company.”
Nano Labs Corp. was founded in October, but has a staff with a background of nearly 30 years of research and development in nanotechnology. More at www.NanoLabs.us.